|
시장보고서
상품코드
1786819
세계의 소아 당뇨병 관리 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 기술별, 제품별, 최종 사용자별, 지역별 시장 예측(2025-2034년)Pediatric Diabetes Management Market Size, Share, Trends, & Industry Analysis Report By Technology (Connected Devices, Non-connected Devices), By Product, By End User, and By Region - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면 소아 당뇨병 관리 시장 규모는 2034년까지 138억 7,000만 달러에 이를 것으로 예측됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
소아 당뇨병 관리는 소아 및 청소년에서 1형 및 2형 당뇨병의 진단, 치료 및 모니터링에 중점을 둡니다. 여기에는 인슐린 요법, 디지털 포도당 모니터링 시스템, 소아 집단을 위해 설계된 통합 관리 접근법 등이 포함됩니다.
소아에서의 1형 당뇨병 및 2형 당뇨병의 이환율 증가, 소아 비만 증가, 대사 이상의 조기 발병은 시장 성장을 가속하는 주요 요인입니다. 또한 인슐린 전달 장치, 연속 혈당 모니터링 장치(CGM)의 기술적 진보, 정부 지원 스크리닝 및 교육 프로그램이 선진국 시장과 신흥국 시장 모두에서 채택을 지원합니다.
소아 당뇨병 관리 시장 보고서 하이라이트
제품별로, 지속 혈당 모니터(CGM) 부문은 소아용 실시간 혈당 추적에 높은 채택으로 인해 가장 빠른 성장이 예상됩니다.
기술별로, 저자원 지역에서의 저렴한 가격 및 사용으로 인해 비연결 부문은 2024년에 압도적인 시장 점유율을 차지했습니다.
최종 사용자별로, 병원 부문은 2024년에 압도적인 시장 점유율을 차지했는데, 이는 높은 진단률과 고급 소아 의료 환경 때문입니다.
북미는 높은 질병 부담, 유리한 상환, 첨단 임상 인프라에 견인되어 2024년 소아 당뇨병 관리 시장 점유율에서 최대를 차지했습니다.
아시아태평양은 당뇨병 이환율 증가, 소아 내분비학 서비스 확대, 의료 접근성 개선 등 예측 기간 동안 크게 성장할 전망입니다.
세계 주요 시장 기업으로는 Medtronic plc, Dexcom, Inc., Abbott Laboratories, Insulet Corporation, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., Ypsomed AG, Ascensia Diabetes Care, Glooko, Inc., AgaMatrix, Inc., EOFlow Co. 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 소아 당뇨병 관리 시장 인사이트
- 시장 현황
- 소아 당뇨병 관리 시장 역학
- 성장 촉진요인 및 기회
- 소아 1형 당뇨병의 세계적 발병률 상승
- 연속 혈당 모니터링(CGM) 및 인슐린 펌프 기술 도입
- 성장 억제요인 및 과제
- 고액의 기기 및 치료비
- 성장 촉진요인 및 기회
- PESTEL 분석
- 소아 당뇨병 관리 시장 동향
- 밸류체인 분석
제5장 세계의 소아 당뇨병 관리 시장 : 제품별
- 주요 조사 결과
- 서문
- 혈당 모니터(BGM)
- 지속 혈당 모니터(CGM)
- 인슐린 펌프
- 인슐린 펜
- 인슐린 주사기
제6장 세계의 소아 당뇨병 관리 시장 : 기술별
- 주요 조사 결과
- 서문
- 커넥티드 디바이스
- 비연결형 디바이스
제7장 세계의 소아 당뇨병 관리 시장 : 최종 사용자별
- 주요 조사 결과
- 서문
- 병원
- 재택 케어
- 소아과 클리닉
제8장 세계의 소아 당뇨병 관리 시장 : 지역별
- 주요 조사 결과
- 서문
- 소아 당뇨병 관리 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 제품별(2020-2034년)
- 북미 : 기술별(2020-2034년)
- 북미 : 최종 사용자별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별(2020-2034년)
- 유럽 : 기술별(2020-2034년)
- 유럽 : 최종 사용자별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별(2020-2034년)
- 아시아태평양 : 기술별(2020-2034년)
- 아시아태평양 : 최종 사용자별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별(2020-2034년)
- 중동 및 아프리카 : 기술별(2020-2034년)
- 중동 및 아프리카 : 최종 사용자별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별(2020-2034년)
- 라틴아메리카 : 기술별(2020-2034년)
- 라틴아메리카 : 최종 사용자별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴, 협업, 합의 및 공개
제10장 기업 프로파일
- Abbott Laboratories
- AgaMatrix, Inc.
- Ascensia Diabetes Care
- Beta Bionics, Inc.
- Dexcom, Inc.
- EOFlow Co., Ltd.
- F. Hoffmann-La Roche Ltd.
- Glooko, Inc.
- Insulet Corporation
- Medtronic plc
- Tandem Diabetes Care, Inc.
- Ypsomed AG
The pediatric diabetes management market size is expected to reach USD 13.87 Billion by 2034, according to a new study by Polaris Market Research. The report "Pediatric Diabetes Management Market Size, Share, Trends, & Industry Analysis Report By Technology (Connected Devices, Non-connected Devices), By Product, By End User, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Pediatric diabetes management focuses on the diagnosis, treatment and monitoring of type 1 and type 2 diabetes in children and adolescents. This includes insulin therapies, digital glucose monitoring systems and integrated care approaches designed for pediatric populations.
Rising incidence of type 1 and type 2 diabetes in children, increasing childhood obesity and early onset of metabolic disorders are key factors driving market growth. Additionally, technological advancements in insulin delivery devices, continuous blood glucose monitoring devices (CGMs), and government-backed screening and education programs are supporting adoption across both developed and emerging markets.
Pediatric Diabetes Management Market Report Highlights
In terms of product, the continuous glucose monitors (CGM) segment is expected to witness the fastest growth, due to high adoption in real-time glucose tracking for pediatric use.
Based on technology, the non-connected segment held the dominant market share in 2024, due to affordability and usage in low-resource regions.
Based on end user, the hospitals segment held the dominant market share in 2024, driven by high diagnosis rates and advanced pediatric care settings.
North America accounted for largest pediatric diabetes management market share in 2024, driven by high disease burden, favorable reimbursement, and advanced clinical infrastructure.
Asia Pacific is expected to grow significantly during the forecast period, fueled by growing diabetes incidence, expanding pediatric endocrinology services and improving healthcare accessibility.
A few global key market players include Medtronic plc, Dexcom, Inc., Abbott Laboratories, Insulet Corporation, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., Ypsomed AG, Ascensia Diabetes Care, Glooko, Inc., AgaMatrix, Inc., EOFlow Co., Ltd., and Beta Bionics, Inc.
Polaris Market Research has segmented the market report on the basis of product, technology, end user, and region:
By Product Outlook (Revenue, USD Billion, 2020-2034)
Blood Glucose Monitors (BGM)
Continuous Glucose Monitors (CGM)
Insulin Pumps
Insulin Pens
Insulin Syringes
By Technology Outlook (Revenue, USD Billion, 2020-2034)
Connected Devices
Non-connected Devices
By End User Outlook (Revenue, USD Billion, 2020-2034)
Hospitals
General Hospitals
Children Hospitals
Homecare
Pediatric Clinics
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Pediatric Diabetes Management Market Insights
- 4.1. Pediatric Diabetes Management Market - Market Snapshot
- 4.2. Pediatric Diabetes Management Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Global Incidence of Pediatric Type 1 Diabetes
- 4.2.1.2. Adoption of Continuous Glucose Monitoring (CGM) and Insulin Pump Technologies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Device and Treatment Costs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Pediatric Diabetes Management Market Trends
- 4.6. Value Chain Analysis
5. Global Pediatric Diabetes Management Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 5.3. Blood Glucose Monitors (BGM)
- 5.3.1. Global Pediatric Diabetes Management Market, by Blood Glucose Monitors (BGM), by Region, 2020-2034 (USD Billion)
- 5.4. Continuous Glucose Monitors (CGM)
- 5.4.1. Global Pediatric Diabetes Management Market, by Continuous Glucose Monitors (CGM), by Region, 2020-2034 (USD Billion)
- 5.5. Insulin Pumps
- 5.5.1. Global Pediatric Diabetes Management Market, by Insulin Pumps, by Region, 2020-2034 (USD Billion)
- 5.6. Insulin Pens
- 5.6.1. Global Pediatric Diabetes Management Market, by Insulin Pens, by Region, 2020-2034 (USD Billion)
- 5.7. Insulin Syringes
- 5.7.1. Global Pediatric Diabetes Management Market, by Insulin Syringes, by Region, 2020-2034 (USD Billion)
6. Global Pediatric Diabetes Management Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 6.3. Connected Devices
- 6.3.1. Global Pediatric Diabetes Management Market, by Connected Devices, by Region, 2020-2034 (USD Billion)
- 6.4. Non-connected Devices
- 6.4.1. Global Pediatric Diabetes Management Market, by Non-connected Devices, by Region, 2020-2034 (USD Billion)
7. Global Pediatric Diabetes Management Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 7.3. Hospitals
- 7.3.1. Global Pediatric Diabetes Management Market, by Hospitals, by Region, 2020-2034 (USD Billion)
- 7.4. Homecare
- 7.4.1. Global Pediatric Diabetes Management Market, by Homecare, by Region, 2020-2034 (USD Billion)
- 7.5. Pediatric Clinics
- 7.5.1. Global Pediatric Diabetes Management Market, by Pediatric Clinics, by Region, 2020-2034 (USD Billion)
8. Global Pediatric Diabetes Management Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Pediatric Diabetes Management Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Pediatric Diabetes Management Market - North America
- 8.3.1. North America: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.3.2. North America: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.3.3. North America: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Pediatric Diabetes Management Market - U.S.
- 8.3.4.1. U.S.: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Pediatric Diabetes Management Market - Canada
- 8.3.5.1. Canada: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4. Pediatric Diabetes Management Market - Europe
- 8.4.1. Europe: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.4.2. Europe: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.4.3. Europe: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Pediatric Diabetes Management Market - UK
- 8.4.4.1. UK: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Pediatric Diabetes Management Market - France
- 8.4.5.1. France: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.4.5.2. France: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.4.5.3. France: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Pediatric Diabetes Management Market - Germany
- 8.4.6.1. Germany: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Pediatric Diabetes Management Market - Italy
- 8.4.7.1. Italy: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Pediatric Diabetes Management Market - Spain
- 8.4.8.1. Spain: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Pediatric Diabetes Management Market - Netherlands
- 8.4.9.1. Netherlands: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Pediatric Diabetes Management Market - Russia
- 8.4.10.1. Russia: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Pediatric Diabetes Management Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5. Pediatric Diabetes Management Market - Asia Pacific
- 8.5.1. Asia Pacific: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Pediatric Diabetes Management Market - China
- 8.5.4.1. China: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.5.4.2. China: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.5.4.3. China: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Pediatric Diabetes Management Market - India
- 8.5.5.1. India: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.5.5.2. India: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.5.5.3. India: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Pediatric Diabetes Management Market - Malaysia
- 8.5.6.1. Malaysia: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Pediatric Diabetes Management Market - Japan
- 8.5.7.1. Japan: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Pediatric Diabetes Management Market - Indonesia
- 8.5.8.1. Indonesia: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Pediatric Diabetes Management Market - South Korea
- 8.5.9.1. South Korea: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Pediatric Diabetes Management Market - Australia
- 8.5.10.1. Australia: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Pediatric Diabetes Management Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.6. Pediatric Diabetes Management Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Pediatric Diabetes Management Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Pediatric Diabetes Management Market - UAE
- 8.6.5.1. UAE: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Pediatric Diabetes Management Market - Israel
- 8.6.6.1. Israel: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Pediatric Diabetes Management Market - South Africa
- 8.6.7.1. South Africa: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Pediatric Diabetes Management Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.7. Pediatric Diabetes Management Market - Latin America
- 8.7.1. Latin America: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Pediatric Diabetes Management Market - Mexico
- 8.7.4.1. Mexico: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Pediatric Diabetes Management Market - Brazil
- 8.7.5.1. Brazil: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Pediatric Diabetes Management Market - Argentina
- 8.7.6.1. Argentina: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Pediatric Diabetes Management Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. AgaMatrix, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Ascensia Diabetes Care
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Beta Bionics, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Dexcom, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. EOFlow Co., Ltd.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. F. Hoffmann-La Roche Ltd.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Glooko, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Insulet Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Medtronic plc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Tandem Diabetes Care, Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Ypsomed AG
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
샘플 요청 목록